Skip to main content

Rivaroxaban

Therapy Area
Anti-Coagulant
API Technology
Synthetic
Formulation
Oral Solids
Development Status
Available
Available Regulatory Filing
USA
Canada
Europe
China
Australia
Philippines
Turkey
Argentina
Thailand
Indonesia
Innovator Brand (US)
XARELTO

We are here to help, if you have any country specific requirements - please Contact Us.